CDC Asks States to Cut Restrictions In Push for Vaccine by Nov. 1: WSJ
Investing.com
Published Sep 02, 2020 04:09PM ET
Updated Sep 02, 2020 04:20PM ET
By Yasin Ebrahim
Investing.com - The Trump administration is reportedly asking states to waive certain requirements to speed up the approval for coronavirus vaccine sites by Nov.1, The Wall Street Journal reported.
“CDC urgently requests your assistance in expediting applications for these distribution facilities and, if necessary, asks that you consider waiving requirements that would prevent these facilities from becoming fully operational by November 1, 2020,” the CDC wrote in letter to state governors, according to the report.
The move marked the latest sign that the Trump administration is seeking to get a vaccine approval before the U.S. election on Nov. 3.
Moderna (NASDAQ:MRNA), the front runner in the race to find a Covid-19 vaccine, was flat in after-hours trade, while rivals Novavax (NASDAQ:NVAX), Pfizer (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) were also largely unchanged.
Get The News You Want
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.